Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging therapeutic targets for treatment of leishmaniasis

2 May 2018

Abstract excerpt

INTRODUCTION: Parasitic diseases that pose a threat to human life include leishmaniasis - caused by protozoan parasite Leishmania species. Existing drugs have limitations due to deleterious side effects like teratogenicity, high cost and drug resistance. This calls for the need to have an insight into therapeutic aspects of disease. Areas covered: We have identified different drug targets via. molecular,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parasites and Host Interactions
Share to Research on Leishmaniasis Studies
Share to Trypanosoma species research and implications

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29718739
DOI: 10.1080/14728222.2018.1472241

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging therapeutic targets for treatment of leishmaniasisPMID 29718739Read ↗

Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug CandidatesSemantic proximity Read ↗

An overview of biochemically characterized drug targets in metabolic pathways of Leishmania parasiteSemantic proximity Read ↗

Glycobiology of theLeishmaniaparasite and emerging targets for antileishmanial drug discoverySemantic proximity Read ↗

Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs.Semantic proximity Read ↗

Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future ProspectsSemantic proximity Read ↗

Kinetoplastid diseases: Insights into the mechanisms of drug action and resistance for novel drug discoverySemantic proximity Read ↗

Molecular Mechanisms of Drug Resistance in Leishmania spp.Semantic proximity Read ↗

The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targetsSemantic proximity Read ↗

The critical role of mode of action studies in kinetoplastid drug discoverySemantic proximity Read ↗

Cutaneous leishmaniasis: therapeutic strategies and future directions.Semantic proximity Read ↗

Novel antimalarial drug targets: hope for new antimalarial drugsSemantic proximity Read ↗

Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.